When President Trump signed the CARES Act, he signaled in a signing statement that he would not enforce some of the oversight provisions in the $2.2 trillion relief and economic stimulus package, included in the bill at the insistence of Democratic leadership. Lawmakers had called for the creation of an independent Pandemic Response Accountability Committee to ensure taxpayer dollars are not misspent, as well as a new position of Special Inspector General for Pandemic Recovery to oversee loans and investments made by the Treasury Secretary, and the White House objected to both provisions in the signing statement. However, it is not clear the statement will have any practical effect on oversight. “Signing statements by themselves do not really do anything …They do not invalidate the law and they do not violate the law,” said one expert.
Regulations, Compliance, & Enforcement
Trending Now
Proposed DFARS Rule Could Require Disclosures and Mitigation Related to Foreign Ownership, Control, and Influence (FOCI) on Certain Unclassified Contracts • OMB Plans to Make IT Contract Data Collection Public, Per Federal CIO • The DOJ Wants Strong FCA Whistleblower Lawsuits From Data Miners • US Investors Earn to Ukrainian Defense Startups—But Export Laws Slow Cooperation • Virginia Expands Restrictions on Employee Non-Compete Agreements
Trump Objects to Pandemic Spending Oversight, But Congress and IGs Still Have Authority
Billion Photos | Shutterstock
Track False Claims Act cases, audit trends, and compliance best practices with our Compliance & Enforcement newsletter, delivering up-to-the-minute intelligence Monday–Saturday — Subscribe here.
